IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women

European Journal of Endocrinology

Volumn 163, Issue 2, 2010, Pages 233-242

  Lewitt, Moira S ^a,b   Hilding, Agneta ^a   Brismar, Kerstin ^a   Efendic, Suad ^a   Östenson, Claes Göran ^a   Hall, Kerstin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1;

ABDOMINAL OBESITY; ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SEX DIFFERENCE; SWEDEN; WAIST CIRCUMFERENCE;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OBESITY, ABDOMINAL; ODDS RATIO; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; SWEDEN; WAIST CIRCUMFERENCE;

EID: 77955383749     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0301     Document Type: Article

References (34)

1. Lee PDK, Giudice LC, Conover CA & Powell DR. Insulin-like growth factor binding protein-1: recent findings and new directions. Proceedings of the Society for Experimental Biology and Medicine 1997 216 319-357. (Pubitemid 27524898)
2. Heald AH, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, Sampayo J, Taylor W, Fraser W, White A & Gibson JM. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001 44 333-339.
3. Kalme T, Seppala M, Qiao Q, Koistinen R, Nissinen A, Harrela M, Loukovaara M, Leinonen P & Tuomilehto J. Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 1550-1556.
4. Rajpathak SN, McGinn AP, Strickler HD, Rohan TE, Pollak M, Cappola AR, Kuller L, Xue X, Newman AB, Strotmeyer ES, Psaty BM & Kaplan RC. Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Hormone and IGF Research 2008 18 166-173.
5. Laughlin GA, Barrett-Connor E, Criqui MH & Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. Journal of Clinical Endocrinology and Metabolism 2004 89 114-120. (Pubitemid 38183869)
6. Lewitt MS, Hilding A, Ostenson CG, Efendic S, Brismar K & Hall K. Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. Diabetologia 2008 51 1135-1145.
7. Colditz GA, Willett WC, Rotnitzky A & Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Annals of Internal Medicine 1995 122 481-486.
8. Dotevall A, Johansson S, Wilhelmsen L & Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabetic Medicine 2004 21 615-622.
9. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V & Kosowski M. Gender-specific care of the patient with diabetes: review and recommendations. Gender Medicine 2006 3 131-158.
10. Regitz-Zagrosek V, Lehmkuhl E & Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology 2006 95 136-147.
11. Mogul HR, Marshall M, Frey M, Burke HB, Wynn PS, Wilker S, Southern AL & Gambert SR. Insulin-like growth factor-binding protein-1 as a marker for hyperinsulinemia in obese menopausal women. Journal of Clinical Endocrinology and Metabolism 1996 81 4492-4495.
12. Gibson JM, Westwood M, Young RJ & White A. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM). Journal of Clinical Endocrinology and Metabolism 1996 81 860-863.
13. Eriksson AK, Ekbom A, Granath F, Hilding A, Efendic S & Ostenson CG. Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabetic Medicine 2008 25 834-842.
14. World Health Organisation. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
15. World Health Organisation. BMI Classification. Retrieved 25 July 2008, from http://www.who.int/bmi/index.jsp?introPage=intro-3.html, 2008.
16. Póvoa G, Roovete A & Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding potein isolated from human amniotic fluid. Acta Endocrinologica 1984 107 563-570. (Pubitemid 15216173)
17. Bang P, Eriksson U, Sara V, Wivall I-L & Hall K. Comparison of acid ethanol extraction and acid gel filtration prior to IGF-I and IGF-II radioimmunoassays: improvement of determinations in acid ethanol extracts by the use of truncated IGF-I as radioligand. Acta Endocrinologica 1991 124 620-629.
18. Herbert V, Lau KS, Gottlieb CW & Bleicher SJ. Coated charcoal immunoassay of insulin. Journal of Clinical Endocrinology and Metabolism 1965 25 1375-1384.
19. Yeoh S-I & Baxter RC. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinologica 1988 119 465-473.
20. Cardim HJ, Lopes CM, Giannella-Neto D, da Fonseca AM & Pinotti JA. The insulin-like growth factor-I system and hormone replacement therapy. Fertility and Sterility 2001 75 282-287.
21. Paassilta M, Karjalainen A, Kervinen K, Savolainen MJ, Heikkinen J, Backstrom AC & Kesaniemi YA. Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels. Atherosclerosis 2000 149 157-162.
22. Suikkari A-M, Tiitinen A, Stenman U-H, Seppälä M & Laatikainen T. Oral contraceptives increase insulin-like growth factor binding protein-1 in women with polycytic ovarian disease. Fertility and Sterility 1991 55 895-899.
23. Diel P, Walter A, Fritzemeier KH, Hegele-Hartung C & Knauthe R. Identification of estrogen regulated genes in Fe33 rat hepatoma cells by differential display polymerase chain reaction and their hormonal regulation in rat liver and uterus. Journal of Steroid Biochemistry and Molecular Biology 1995 55 363-373. (Pubitemid 26017221)
24. Veldhuis JD, Frystyk J, Iranmanesh A & Orskov H. Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations. Journal of Clinical Endocrinology and Metabolism 2005 90 2941-2947.
25. Hilding A, Brismar K, Degerblad M, Thorén M & Hall K. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 2646-2652.
26. Suikkari A-M, Koivisto VA, Koistinen R, Seppälä M & Yki-Järvinen H. Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. Journal of Clinical Endocrinology and Metabolism 1989 68 135-140.
27. Conover CA, Lee PDK, Kanaley JA, Clarkson JT & Jenson MD. Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. Journal of Clinical Endocrinology and Metabolism 1992 74 1355-1360.
28. Weaver JU, Holly JMP, Kopelman PG, Noonan K, Giadom CG, White N, Virdee S & Wass JAH. Decreased sex hormone binding globulin (SHBG) and insulin-like growth factor binding protein (IGFBP-1) in extreme obesity. Clinical Endocrinology 1990 33 415-422.
29. Kotronen A, Vehkavaara S, Seppala-Lindroos A, Bergholm R & Yki-Jarvinen H. Effect of liver fat on insulin clearance. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E1709-E1715. (Pubitemid 350255123)
30. Kotronen A, Lewitt M, Hall K, Brismar K & Yki-Järvinen H. Insulin-like growth factor binding protein 1 as a novel specific marker of hepatic insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 2008 93 4867-4872.
31. Petersson U, Östgren CJ, Brudin L, Brismar K & Nilsson PM. Low levels of insulin-like growth factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study. Diabetes & Metabolism 2009 35 198-205.
32. Laakso M. Prevention of type 2 diabetes. Current Molecular Medicine 2005 5 365-374.
33. Steinbaum SR. Themetabolic syndrome: an emerging health epidemic in women. Progress in Cardiovascular Diseases 2004 46 321-336.
34. Lee CM, Huxley RR, Wildman RP & Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. Journal of Clinical Epidemiology 2008 61 646-653.